ISBT 2025

Roche Products in Australia looks forward to welcoming you to the Roche Booth and events at the upcoming BLOOD 2025 and the 36th Regional Congress of the ISBT meeting in Perth.

A healthier future - that’s what drives us. Throughout our 128-year history, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas. Our commitment to our people, partners, stakeholders and, most importantly, patients remains as strong as it was on the first day of our journey. At Roche, we are doing now what patients need next.

We have a global ambition to deliver 20 transformative medicines by 2030, addressing diseases with the highest societal burden. Our focus is on end-to-end investment in 11 diseases across 5 therapy areas which account for the bulk of global disease burden: oncology & haematology, neurology, ophthalmology, immunology and cardiovascular-metabolism.

With a heritage in respect for a healthy planet, Roche’s sustainability approach supports the UN Sustainable Development Goals. We are committed to the Science Based Targets initiative and the Sustainable Markets Initiative to achieve net zero by 2045.

For more than 65 years, Roche Diagnostics Australia has been delivering healthcare solutions to Australians. Our team of nearly 200 people across five locations works together to achieve our shared goal through innovative platforms, lifesaving assays and workflow-enhancing solutions.

Haematology is a complex and vital area of medicine, and we remain committed to advancing progress across the field. We collaborate with blood banks, laboratories and healthcare providers to support accurate testing and timely decision-making, from donor screening to patient care.

Our solutions address a broad range of blood-related needs – from improving transfusion safety and plasma screening to supporting the detection and management of blood disorders, cancers and rare conditions. We continue to explore new ways to bring innovation to healthcare, whether through advanced diagnostics, smarter clinical trials or improved ways to measure patient outcomes.

Today, we are committed to our purpose of providing better healthcare outcomes for everyone in Australia.

Delivering confidence in transfusion safety from donor to patient.

Roche Blood Safety Solutions (RBSS) looks forward to welcoming you to our booth and events at the upcoming Blood 2025 and the 36th Regional Congress of the ISBT meeting in Perth.

Roche offers the most comprehensive and integrated solution for screening whole blood and plasma donations optimized to meet your needs and designed to work together for maximum efficiency.